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Middle East respiratory syndrome coronavirus (MERS-CoV) is a novel coronavirus that causes 36 pneumonia in humans, which may lead to acute respiratory distress syndrome (1). Currently 37 more than 1500 confirmed cases have been reported with a relatively high case fatality rate.
38
Although most MERS outbreaks have been reported in the Middle Eastern countries, travel-39 related cases may seed outbreaks in other regions, such as in South Korea (2). In principle, they 40 can be controlled through implementation of early viral diagnostics, strict hygiene measures, and 41 isolation of patients. However, there is still a lack of understanding how this virus is transmitted,
42
both between humans and from camels to humans.
43
Dromedary camels are currently considered as the only zoonotic source of This is largely based on the fact that closely related viruses have only been isolated from this shown that only 2-3 % of persons in Saudi Arabia and Qatar that come into close contact with 49 dromedary camels have neutralizing antibodies to MERS-CoV (5, 9). Additionally, most notified 50 MERS patients to date did not report any contact with camels or other livestock animals, 51 consistent with the fact that most outbreaks took place in hospitals (7, 8 performed on these FFPE tissue sections with 3 µm thickness. Antigen was retrieved by boiling 79 these sections in citric acid buffer 10.0 M pH 6 for 15 minutes using 600W microwave.
80
Endogenous peroxidase was blocked by incubating the slides with hydrogen peroxidase 3% for 81 10 minutes. DPP4 was detected using 5 µg/ml polyclonal goat IgG anti-human DPP4 antibody 82 (R&D systems, Abingdon, UK), while negative controls were stained using normal goat serum 
89
In the human respiratory tract tissues, DPP4 was detected in the lower part, i.e. alveolar 90 epithelial cells and macrophages, but mostly type II alveolar epithelial cells (Fig. 1 ). In addition,
91
DPP4 expression was also limitedly detected on the apical surface of the terminal bronchioles 92 and bronchial epithelium of two lungs and one bronchus samples. In sharp contrast, DPP4 was 93 not detected in the nasal respiratory and olfactory epithelium nor the trachea in any of our 94 samples (Fig. 1) . In the submucosal layer of these tissues, DPP4 was detected in the serous 95 glandular epithelium, inflammatory cells, and vascular endothelium. In contrast to humans, 96 DPP4 was detected in the ciliated epithelial cells of the upper respiratory tract epithelium of 97 dromedary camels (Fig. 1) . Additionally, it was also present in the ciliated epithelial cells of the RNAscope® platform (18) with commercially available probes for DPP4, mRNA was detected 105 in human submucosal glands, but not in the nasal epithelium of the nose ( Fig. 2A and B were cut. Kidney was again used as a DPP4 positive control. These sections were fixated in 125 acetone and incubated in room temperature for 1 hour with 1 µg/ml of either mFc-S1 MERS-
126
CoV, mFc-S1 OC4, mFc-S1 PEDV, MAb anti-DPP4, or isotype mouse antibody. They were 127 subsequently incubated with peroxidase-labeled goat anti-mouse IgG (DAKO, Glostrup, 128 Denmark) in 1:100 dilution for 1 hour at room temperature and processed as described above. As 129 shown, mFc-S1 OC43 bound to the surface of nasal epithelium, while mFc-S1 MERS and MAb 130 anti-DPP4 did not. Similar to our results depicted in figure 1 and 2 , mFc-S1 MERS-CoV and
131
MAb anti-DPP4 bound to the nasal submucosal glands and kidney proximal tubuli. Meanwhile, 132 our negative control, mFc-S1 PEDV and mouse isotype antibodies, did not show binding to 133 either nasal or kidney tissues (Fig. 3) . This result suggests that neither DPP4 nor any other human DPP4 (MAb anti-DPP4) showed similar binding as mFc-S1 MERS-CoV. S1 protein of 309 OC43 (mFc-S1 OC43) binds to the nasal epithelium (indicated by arrows) and was used as a 310 positive control. As a negative control, S1 protein of porcine epidemic diarrhea virus (mFc-S1 311
